Skip to main content

Rituximab: MS Clinical Trials

6 active trials · 3 recruiting

6 active multiple sclerosis clinical trials involve Rituximab, 3 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.

Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.

Active Rituximab MS trials

RecruitingPhase 2

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

Sponsor: Cairo University
Rituximab · Saline (NaCl 0,9 %) (placebo)
46 participantsDetails ›
RecruitingPhase 3

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.

Sponsor: Rennes University Hospital
Perfusion of treatment Rituximab · Perfusion of treatment Ocrelizumab
386 participantsDetails ›
RecruitingPhase 3

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Sponsor: Amsterdam UMC, location VUmc
Rituximab
200 participantsDetails ›
Closed to new patientsNA

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Sponsor: Johns Hopkins University
Natalizumab/natalizumab-sztn, Alemtuz… · Glatiramer acetate, Interferons (intr…
28 states900 participantsDetails ›
Closed to new patientsPhase 3

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Sponsor: Rigshospitalet, Denmark
Rituximab · Ocrelizumab
600 participantsDetails ›
Closed to new patientsPhase 3

Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

Sponsor: Haukeland University Hospital
Rituximab · Ocrelizumab
214 participantsDetails ›

MS trials by therapy

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play